Why U.S. Regulators Are Cracking Down on Private Equity Investments in the Healthcare Sector
July 30, 2026
Global Competition Review – Americas Antitrust Review 2027
Axinn managing partner Jeny Maier, counsel Monica Smith, and associate Leandra Ipiña co-authored a chapter in Global Competition Review’s Americas Antitrust Review 2027 titled “Why U.S. Regulators Are Cracking Down on Private Equity Investments in the Healthcare Sector.”
Click here to access the chapter.
Accreditation: This article was first published on Global Competition Review in July 2026; for further in-depth analysis, please visit GCR - Americas Antitrust Review 2027
To subscribe to our publications, click here.
Featured Insights
Featured Insights
30th Annual IBA Competition Conference
Speaking Engagement
Antitrust
Axinn Represents Modular in $4 Billion Acquisition by Qualcomm
Deals & Cases
Antitrust
Will New DOJ Timing Agreement Deliver Faster Merger Clearances?
Axinn Viewpoints
Antitrust
Women Leaders in Life Sciences Law
Speaking Engagement
Litigation & Trials
American Bar Association: Inside Antitrust Enforcement—Former Government Perspectives
Webinar
Antitrust
What's the Skinny on SCOTUS' Skinny Label Decision?
Webinar
Intellectual Property
National Bar Association Corporate Counsel Leadership Summit
Speaking Engagement
Antitrust
FTC Prescribes Lower Out-of-Pocket Insulin Costs in Settlement with Caremark
Axinn Viewpoints
Antitrust
The FTC’s Record $12 Million HSR Penalty: Deal Structuring, Avoidance, and the Line Between Them
Axinn Viewpoints
Antitrust
DC Bar: The DOJ's New Antitrust Whistleblower Rewards Program: An Overview and the Road Ahead
Speaking Engagement
Antitrust